event,time
numbness and weakness in lower extremities ,-720
numbness and weakness progressed to hands and neck ,-720
presumptive diagnosis of Guillain-Barré syndrome (GBS) ,-720
admission to community hospital ,0
lumbar puncture ,0
albuminocytologic dissociation in cerebrospinal fluid ,0
brain magnetic resonance imaging (MRI) scan ,0
small vessel ischemic changes ,0
intravenous immunoglobulin (IVIG) treatment ,0
worsening pancytopenia ,120
encephalopathy ,120
transfer to specialist center ,120
hypotensive ,120
unresponsive to verbal stimuli ,120
minimally responsive to painful stimuli ,120
Glasgow Coma Scale (GCS) score of 6 ,120
anasarcic ,120
flaccid paralysis of all four extremities ,120
malnourished and septic state ,120
calcium of 6.7 mg/dL ,120
hemoglobin of 9.4 g/dL ,120
white cell count of 2.1×10^9/L ,120
phosphorus of 1.1 mg/dL ,120
creatinine <0.2 mg/dL ,120
albumin <1.5 gm/dL ,120
lactate of 4 mmol/L ,120
nutritional risk screening (NRS-2002) score of 5 ,120
malnutrition universal screening (MUST) score of 5 ,120
intubated ,120
resuscitated with intravenous fluids ,120
intravenous infusion of norepinephrine ,120
meropenem treatment ,120
vancomycin treatment ,120
anidulafungin treatment ,120
empirical treatment with high-dose intravenous thiamine ,120
electroencephalogram (EEG) ,168
diffuse slow waves ,168
severe metabolic encephalopathy ,168
brain magnetic resonance imaging (MRI) scan ,216
hyperintensity of bilateral medial thalamus ,216
Wernicke’s encephalopathy ,216
serum thiamine level of 104 nmol/L ,216
improved mental status ,288
able to understand simple commands ,288
discontinuation of norepinephrine ,288
discontinuation of antimicrobial treatment ,288
extubated ,360
electromyography (EMG) ,504
severe sensorimotor polyneuropathy ,504
transferred out of intensive care unit (ICU) ,1008
discharge ,1008
thiamine supplementation ,0
